BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22761949)

  • 21. A novel canine lymphoma cell line: a translational and comparative model for lymphoma research.
    Kisseberth WC; Nadella MV; Breen M; Thomas R; Duke SE; Murahari S; Kosarek CE; Vernau W; Avery AC; Burkhard MJ; Rosol TJ
    Leuk Res; 2007 Dec; 31(12):1709-20. PubMed ID: 17532464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma.
    Amini RM; Berglund M; Rosenquist R; Von Heideman A; Lagercrantz S; Thunberg U; Bergh J; Sundström C; Glimelius B; Enblad G
    Leuk Lymphoma; 2002 Nov; 43(11):2179-89. PubMed ID: 12533045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel canine T-cell line established from a spontaneously occurring aggressive T-cell lymphoma with large granular cell morphology.
    Bonnefont-Rebeix C; Fournel-Fleury C; Ponce F; Belluco S; Watrelot D; Bouteille SE; Rapiteau S; Razanajaona-Doll D; Pin JJ; Leroux C; Marchal T
    Immunobiology; 2016 Jan; 221(1):12-22. PubMed ID: 26345430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes.
    Haran KP; Lockhart A; Xiong A; Radaelli E; Savickas PJ; Posey A; Mason NJ
    Vet Pathol; 2020 Mar; 57(2):241-252. PubMed ID: 32081102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.
    Sambade C; Berglund M; Lagercrantz S; Sällström J; Reis RM; Enblad G; Glimelius B; Sundström C
    Int J Cancer; 2006 Feb; 118(3):555-63. PubMed ID: 16106419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer.
    Dickerson EB; Fosmire S; Padilla ML; Modiano JF; Helfand SC
    J Immunother; 2002; 25(1):36-45. PubMed ID: 11924909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.
    Liu W; Beck J; Schmidt LC; Roolf C; Pews-Davtyan A; Rütgen BC; Hammer S; Willenbrock S; Sekora A; Rolfs A; Beller M; Brenig B; Nolte I; Junghanss C; Schütz E; Murua Escobar H
    Oncotarget; 2016 Jun; 7(23):35379-89. PubMed ID: 27177088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach.
    Da Ros S; Aresu L; Ferraresso S; Zorzan E; Gaudio E; Bertoni F; Dacasto M; Giantin M
    PLoS One; 2018; 13(12):e0208709. PubMed ID: 30533020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model.
    Umeki S; Ema Y; Suzuki R; Kubo M; Hayashi T; Okamura Y; Yamazaki J; Tsujimoto H; Tani K; Hiraoka H; Okuda M; Mizuno T
    J Vet Med Sci; 2013 May; 75(4):467-74. PubMed ID: 23196801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma.
    Stein L; Bacmeister C; Ylaya K; Fetsch P; Wang Z; Hewitt SM; Kiupel M
    Vet Pathol; 2019 May; 56(3):350-357. PubMed ID: 30636524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
    Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
    J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic characterization of canine malignant lymphoma: a retrospective study of cases diagnosed in Poland Lower Silesia, over the period 2011-2013.
    Pawlak A; Rapak A; Drynda A; Poradowski D; Zbyryt I; Dzimira S; Suchański J; Obmińska-Mrukowicz B
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():52-60. PubMed ID: 25052381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.
    Li Z; Mahesh SP; Shen DF; Liu B; Siu WO; Hwang FS; Wang QC; Chan CC; Pastan I; Nussenblatt RB
    Cancer Res; 2006 Nov; 66(21):10586-93. PubMed ID: 17079483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line.
    Chen W; Liu I; Tomiyasu H; Lee J; Cheng C; Liao AT; Liu B; Liu C; Lin C
    Vet J; 2019 Dec; 254():105398. PubMed ID: 31836165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
    Guija de Arespacochaga A; Schwendenwein I; Weissenböck H
    J Comp Pathol; 2007; 136(2-3):186-92. PubMed ID: 17416237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of degree of malignancy in non-Hodgkin B-cell lymphoma with immunophenotyping].
    Dzembak TM; Gurkalo VK; Gershanovich ML
    Vopr Onkol; 1998; 44(2):187-9. PubMed ID: 9615824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning and expression analysis of the canine chemokine receptor CCR9.
    Maeda S; Ohno K; Tsukamoto A; Nakashima K; Fukushima K; Goto-Koshino Y; Fujino Y; Tsujimoto H
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):534-9. PubMed ID: 22209203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homing and antigenic characterization of a human non-Hodgkin's lymphoma B cell line in severe combined immunodeficient (SCID) mice.
    de Kroon JF; Kluin PM; Kluin-Nelemans HC; Willemze R; Falkenburg JH
    Leukemia; 1994 Aug; 8(8):1385-91. PubMed ID: 8057678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.